Willis Knighton Physicians Network — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$13,369	12
2023	Research	$24,069	42
2022	Research	$57,631	24
2021	Research	$7,455	4

Breakdown

Who paid Research payments · program years 2021–2024

Takeda Pharmaceuticals U.S.A., Inc. $49,643 54 payments
Sanofi Pasteur Inc. $25,491 16 payments
MorphoSys AG $13,645 6 payments
GlaxoSmithKline, LLC. $10,696 1 payment
Sanofi US Services Inc. $3,050 5 payments

Studies the money was for Research payments · program years 2021–2024

Phase 3, Multicenter, Randomized Study With 2 Different Doses of Prucalopride Administered to Male and Female Pediatric Subjects Aged 6 Months to 17 Years With Functional Constipation, Consisting of A 12-Week Double-Blind, Placebo-Controlled Part (Part A) to Evaluate Efficacy and Safety Followed By A 36-Week Double-Blind Extension Part (Part B) to Document Long-Term Safety Up to Week 48 $49,643 54 payments
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $28,541 21 payments
realMIND: Observational Study of Patients With Relapsed or Refractory DLBCL Starting Second- or Third-line Therapy (realMIND) $13,645 6 payments
A Phase II, Observer-Blind, Randomized, Controlled Study to Evaluate T $10,696 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.